Yabao Pharmaceutical Group Co Ltd banner
Y

Yabao Pharmaceutical Group Co Ltd
SSE:600351

Watchlist Manager
Yabao Pharmaceutical Group Co Ltd
SSE:600351
Watchlist
Price: 6.68 CNY 3.09% Market Closed
Market Cap: ¥4.6B

Wall Street
Price Targets

Price Targets Summary
Yabao Pharmaceutical Group Co Ltd

There are no price targets for Yabao Pharmaceutical Group Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Yabao Pharmaceutical Group Co Ltd Competitors:
Price Targets

Revenue
Forecast

4% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's revenue is 4%. The projected CAGR for the next 6 years is 3%.

Operating Income
Forecast

1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
1% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's operating income is 1%. The projected CAGR for the next 10 years is -4%.

Net Income
Forecast

2% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
2% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's net income is 2%. The projected CAGR for the next 6 years is 1%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yabao Pharmaceutical Group Co Ltd's stock price target?
Not Available

Yabao Pharmaceutical Group Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Yabao Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's revenue is 4%. The projected CAGR for the next 6 years is 3%.

What is Yabao Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's operating income is 1%. The projected CAGR for the next 10 years is -4%.

What is Yabao Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Yabao Pharmaceutical Group Co Ltd's net income is 2%. The projected CAGR for the next 6 years is 1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett